• Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

Eli Lilly’s LillyDirect: Implications for Direct-to-Consumer Women’s Health Startups

By Kathrin Folkendt Digital Health, Ecosystem, News, Pharma, Trend Watch January 8, 2024
ShareTwitterFacebookPinterest-circled
  • Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

To continue reading…

Become a premium member and get unlimited access to articles, weekly analysis, free access to out webinars and more:

Subscribe

Already a subscriber? Log in here.

You May Also Like

Career, News, Women's Health March 12, 2021
Women’s Health USA Appoints Two New Executives to Leadership Team
Investment, Menstrual Health, News August 24, 2022
Femtech Startup 28 Raises $3.2M in Seed Funding for Its Cycle-focused Wellness Program
Written By
Kathrin Folkendt

Kathrin Folkendt is the Founder & CEO of Femtech Insider, the globally leading publication on all things femtech. She usually writes about women's health innovation, health equity, and entrepreneurship.

Featured Events

    From Niche to Necessity:The Menopause Market’s Next Chapter

    2026-02-26
    Online Event
Recent Posts
  • Germany Invests €12 Million in Non-Hormonal Contraception Research
  • Daré Bioscience Launches Telehealth Access for DARE to PLAY, Its Topical Sildenafil Cream for Women
  • Kindbody Announces Platform Updates Including Pregnancy App, Menopause Program, and Expanded Network
  • Agilent Receives FDA Approval for Companion Diagnostic in Ovarian Cancer
  • FDA Approves Merck’s Keytruda for Platinum-Resistant Ovarian Cancer

About Femtech Insider

Advertise with us!

Become a Member!

Contact us

Privacy Policy // Terms of Use

Femtech Insider Ltd. © 2026. All rights reserved.